Items with tag "academia"

News

Ghent University starts search for 21 top professors

7th September 2018 During the next few years, the faculties at Ghent University will more closely collaborate with each other in the realisation of ten interdisciplinary projects of major soci…

Read more

Janssen to team up with UGent and UZ Gent in industry-academia collaboration

Janssen Pharmaceutica have signed a renewal of the innovation charter with Ghent University (UGent) and Ghent University Hospital (UZ Gent). The move is part of an initiative to share more knowled…

Read more

CRISPR eliminates heart disease in embryos

American and South Korean scientists have successfully removed a part of the genome of human embryos using CRISPR-Cas9 to eradicate a hereditary heart disease, according to a study published in Na…

Read more

New drug for intestinal fibrosis

Researchers from Ghent University Hospital have forced a breakthrough in the fight against intestinal fibrosis, a complication that occurs especially in patients with Crohn's disease. Today, intes…

Read more

Breakthrough in separating left- and right-handed molecules

In a discovery with broad implications for the specialty chemicals industries like pharmaceuticals, researchers at Rice University and the California Institute of Technology have succeeded in a de…

Read more

Halving of new HIV infections by 2030 through better prevention

Belgium counts more than 1,000 new HIV infections each year, which is a lot compared to other European countries. Fortunately, an HIV infection is no longer a death sentence. With the available tr…

Read more

GiGa determines genetic culprits causing IBD

In a study published in Nature last week, scientists from GiGa (ULg) examined the genome of 67,852 individuals and applied three statistical methods to zoom in on which genetic variants were activ…

Read more

Scientists give tumor-fighting cells a boost in battling bone marrow cancer

Researchers from VIB-Ghent University and the VUB uncovered a new way to enhance the function of a specific type of immune cell that destroys tumors in multiple myeloma, a form of bone marrow canc…

Read more

Progranulin shortage could cause frontotemporal dementia

In a recent study in Human Molecular Genetics, researchers from VIB  and KU Leuven led by Prof. Philip Van Damme, reveal a novel function for progranulin in lysosomes: it acts as chaperone of the …

Read more

Polluted air can generate power

Researchers from the University of Antwerp and KU Leuven have succeeded in developing a process that purifies air and, at the same time, generates power. The device must only be exposed to light i…

Read more

Coffee value can be predicted without tasting

A novel method developed at Ghent University (Belgium) can predict the value of Ethiopian coffee without any tasting. As baristas undoubtedly will confirm, consumers nowadays attach greater import…

Read more

A new unexpected key player in melanoma development identified

Identification and functional validation of proteins involved in tumorigenesis are essential steps toward advancing cancer precision medicine. In The Journal of Clinical Investigation researchers …

Read more

Characterising the profile of metastatic breast cancer for improved treatment

Researchers at the Jules Bordet Institute - Université libre de Bruxelles, VIB and KU Leuven recently published an important study offering a better understanding of the progression of breast canc…

Read more

How Europe responds to the demise of the fire salamander

A killer fungus threatens European salamanders with extinction and there are currently very few options to prevent this from happening, scientists have warned. Time for Europe to take action. In a…

Read more

Researchers discover mechanism behind central allergy protein

VIB-UGent researchers unravel the functioning of what is believed to be the master protein that drives a range of allergic diseases, TSLP. These insight allowed the researchers to develop a first …

Read more

Glucose starvation as a weapon in breast cancer

The Massimiliano Mazzone group (VIB-KU Leuven) has recently demonstrated that PP2A/B55α promotes the growth of colorectal cancer, by dephosphorylating PHD2 and modifying its enzymatic properties.

Read more

Protein clumps cause ALS and FTLD

Scientists from Belgium, the UK and the US have identified new processes that form protein “clumps” that are characteristic of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degenera…

Read more

Ghent University raises its profile in precision agriculture

On 15 March Ghent University officially launched a prestigious research project on precision agriculture, led by the Syrian-Belgian top scientist Abdul Mouazen.

Read more

EU-LIFE calls for an increased European Research Council budget

EU-LIFE, the alliance of European research centres in life sciences, urges politicians to unequivocally support the ERC by raising its budget in FP9 and endorsing its guiding principles. 

Read more

Follow Ghent University's guideline to analyze extracellular vesicles

Researchers from Ghent University published a knowledge bank in Nature Methods to increase reproducibility of research on extracellular vesicles. Extracellular vesicles (EV) are tiny cell fragment…

Read more

Four times more funds for VIB

The Flemish Government will increase the annual support for the VIB from 15 million to 59 million per year. "The VIB is the catalyst of the Flemish biotechnology sector. It's an excellent referenc…

Read more

Francqui Chair 2016-2017 has started

Last Tuesday, the international Francqui Chair 2016-2017 was inaugurated with a lecture on 'Changing the face of modern medicine: gene therapy and gene editing', by Thierry VandenDriessche at Ghen…

Read more

Researchers identify phosphorylation process vital to cancer growth

Scientists at VIB-KU Leuven have identified a new mechanism that impacts tumor growth. The typical lack of oxygen in tumors doesn’t only stimulate proliferation, but also offsets the important rol…

Read more

Scientists isolate new antibodies to fight RSV

Researchers from VIB, UGent, the Geisel School of Medicine at Dartmouth and several collaborators developed a new antiviral strategy to fight human respiratory syncytial virus (RSV), a leading cau…

Read more

Mitochondrial lipids as potential targets in early onset Parkinson’s disease

A team of researchers led by Patrik Verstreken (VIB–KU Leuven) have identified an underlying mechanism in early onset Parkinson’s. Using flies, mice and patient cells, the team focused on cardioli…

Read more

Human nose home to five types of bacteria

Researchers from the University of Antwerp have concluded that the organisms in our noses can be divided into five different types. Prof. Sarah Lebeer (UAntwerp) says: “This new knowledge will eve…

Read more

Physical barrier in microscopy overcome by VIB scientists

Confocal microscopy, which enables scientists to construct 3D representations of objects in the range of hundreds of nanometer, has been the workhorse and method of choice for imaging for decades …

Read more

Scientists use tumor-derived dendritic cells to slow tumor growth

​In the human body, so-called dendritic cells are responsible for activating our immune system. While researchers previously believed that tumors could repress these dendritic cells – blocking an …

Read more

Protein found that drives allergic sensitivity in newborns

Scientists from the lab of Bart Lambrecht (VIB-UGent) and Erasmus University have found evidence that interleukin-33 (IL-33), a protein created by white blood cells, is a key driver of allergic se…

Read more

ULB elucidates part of brain construction process

The construction during the embryogenesis of the cerebral cortex, the main site of cognitive functions, remains a mysterious process: at present, only a few transcription factors essential for the…

Read more

New insights in genetic defect allow prevention of fatal illnesses in children

A team of scientists led by prof. Adrian Liston (VIB–KU Leuven) and prof. Isabelle Meyts (UZ Leuven – KU Leuven) were able to characterize a new genetic immunodeficiency resulting from a mutation …

Read more

Cystic Fibrosis research projects wanted!

Call for research grants by Fund Alphonse & Jean Forton, managed by the King Baudouin Foundation, and Belgian Cystic Fibrosis Association.

Read more

ULg receives WHO prequalifaction for drug control

After being the first European university to receive the GMP (Good Manufacturing Practices) certification for the quality control of drugs in 2014, ULg is now also the first university in the worl…

Read more

GiGa gets one step closer to curing atopic dermatitis

Atopic dermatitis (AD) affects up to 20% of children worldwide. It is the most common inflammatory skin disease, characterized by pruritus, eczema and abnormal IgE responses to environmental subst…

Read more

60 million euro for KU Leuven's Centre for Drug Design and Discovery

The Centre for Drug Design & Discovery (CD3) has launched a 60 million euro fund to turn innovative biomedical research of academic institutions and small companies into drugs that improve and ext…

Read more

Autophagy research wins Yoshinori Ohsumi Nobel Prize

Nobel Prize season 2016 has arrived and the one to take the first spot is the Nobel Prize in Physiology or Medicine. The prestigious prize was awarded to Yoshinori Ohsumi for his discoveries of me…

Read more

New treatment for urinary tract infections

Scientists from VIB-VUB discovered an important aspect in the development of urinary tract infections. Researchers from VIB and VUB joined hands with the US Center for Women's Infectious Disease R…

Read more

Belgian rheumatology among Europe’s finest

When it comes to research into rheumatology, Belgium is playing at the top of the league. For the third time in a row, an alliance of Ghent-based researchers and clinicians has been awarded the pr…

Read more

New strategic VIB - BioPontis Alliance for Rare Diseases

The VIB has announced its first research project in collaboration with the Biopontis Alliance for Rare Diseases. The study is aimed at developing a treatment for Charcot-Marie-Tooth disease and is…

Read more

Increase oxygen to fight cancer

​The lack of oxygen in tumor cells changes the cells’ gene expression, thereby contributing to the growth of cancer. This is the main conclusion of a research project led by professor Diether Lamb…

Read more

Breakthrough in understanding dystonia

Are cellular lipids the missing link between a faulty gene and a neurological disorder?   Researchers at VIB-KU Leuven have managed to get a clearer view on the roots of dystonia, a n…

Read more

VIB-KULeuven/ULB research team discover new cancer target

In a collaborative effort, researchers of the labs of Jean-Christophe Marine (VIB-KULeuven) and Cédric Blanpain (ULB) have discovered an intriguing novel target for cancer therapy. NEAT1, a non-co…

Read more

Quitting HIV treatment for the sake of science

With a temporary therapy stop, researchers from Ghent University and UZ Gent want to examine a new route to cure HIV. The research, led by Professor Linos Vandekerckhove, is unique in the world an…

Read more

Solving the C-mystery

The carbon cycle is one of the most important geochemical processes for life on earth, since it has a huge impact on climate and carbon is the central molecule of countless biological compounds. S…

Read more

New type of cod can be cultured in Belgium!

Researchers from the University College Odisee, campus Waas in Sint-Niklaas, managed to grow a cod species that is suitable for cultivation in Belgium. This should enable local cod farmers to more…

Read more

Hep C drug also active against zika

Scientists from KU Leuven have shown that the experimental antiviral drug 7DMA against hepatitis C slows down the development of the Zika virus in mice. The study, carried out by the Laboratory of…

Read more

First map of the Belgian microbiome

The human body naturally hosts 1,000 trillion microbial cells, the so called microbiome, which on itself is essential for the proper functioning of our bodies. The microbiome has been linked to di…

Read more

Algae: the new gold?

Algae production is a technology with great potential and could mean a solution to many environmental problems, but a real breakthrough still has to happen. "More research is needed to make the pr…

Read more

Stem cells in baby urine to treat kidney disease

Patients with a kidney disease or injury can sometimes be helped with a specific type of stem cells. An international team led by Professor Elena Levtchenko from KU Leuven has now discovered that …

Read more

Silencing the communication between bacteria increases their vulnerability

Treatment of an MRSA (Methicillin-resistant Staphylococcus aureus) infection often is very difficult, as these bacteria are resistant to many antibiotics. In addition, these bacteria often reside …

Read more

Hay fever medicine to treat IBS

KU Leuven researchers have traced the cause of abdominal pain in patients with irritable bowel syndrome (IBS). They also found out which compound could reduce or eliminate pain. It is the same sub…

Read more

How Helicobacter clings on to our stomach

The bacterium Helicobacter pylori is a known gastric pathogen and causes the bulk of peptic ulcer and gastric cancer cases. H. pylori can survive in the hostile environment of the stomach by tight…

Read more

Bacterial defense mechanism against bleach assault uncovered

As a response to infection, our immune cells release antimicrobial ‘bleach’ to destroy surrounding bacteria. Researchers at the de Duve Institute and the UCL, in collaboration with the University …

Read more

New VIB-UHasselt research group to tackle MS

VIB and UHasselt have teamed up for the creation of a new research group. After an international selection procedure, renowned German professor Markus Kleinewietfeld was appointed to lead the newl…

Read more

Promising gene therapy for cystic fibrosis

Scientists from the research group Molecular Virology and Gene Therapy of the University of Leuven have developed a new form of gene therapy that is able to cure mice with cystic fibrosis. Also, c…

Read more

GlycoCirrho test predicts liver cancer

Researchers at the UZ Ghent have discovered that the GlycoCirrhoTest for the early detection of cirrhosis also accurately predicts the risk for the development of liver cancer. Their results are p…

Read more

New biodegradable gauze for better wound healing

Researchers from the universities of Hasselt, Liege, Aachen and Maastricht developed new 'plastics' that are biodegradable by the body and which could replace the traditional gauze bandage for wou…

Read more

Treatment for venous malformations on its way

Malformation of the veins is a seriously incapacitating condition and causes pain, local blood clotting and deforming lesions, which enlarge over time. These venous anomalies consist of enlarged v…

Read more

Why beta-cells are destroyed in type 1 diabetes

Researchers at the ULB Center for Diabetes Research have uncovered a possible mechanism of pancreatic β cell destruction in type 1 diabetes (T1D). Gene expression analyses revealed a different ind…

Read more

VIB is number one in patent citations

Ranking innovation is not easy, but Times Higher Education has taken measures based on the quality of universities’ partnerships with industry. The Times survey ranks institutions on four innovati…

Read more

Processing paper waste with panda feces

Scientists from the University of Ghent will study the feces of Hao Hao and Xing Hui, the two giant pandas from Pairi Daiza animal park. They hope to discover how paper waste can be processed more…

Read more

Results disputed potato field trial finally published

The stacking of genes is necessary for a strong and lasting resistance to Phytophthora blight. These are the scientific results of the potato field trials in Flanders and the Netherlands. Rese…

Read more

Prof. Carmeliet as Chief Scientific Strategy Advisor at Oncurious

Oncurious NV, an oncology company focused on the development of innovative medicines for the treatment of pediatric tumors, today announces the appointment of Prof Dr Peter Carmeliet as its Chief …

Read more

Undizzy you by crowdfunding “Dizzy Me”

Tania Stadsbader, a patient who suffered more than 10 years from dizziness, and Floris Wuyts, professor in Physics at UA, head of AUREA (Antwerps Universitair Researchcentrum voor Evenwicht) and A…

Read more

Take your own venture and make it a business case

The Executive Master of Business Innovation & Entrepreneurship in Life Sciences & Health (MBI Life Sciences and Health) is a unique ‘hands-on’ MBA program to accelerate life sciences ventures or b…

Read more

Become MSc in Bioinformatics!

Next year, it will be possible to obtain an MSc in Bioinformatics at Ghent University. It is a new interdisciplinary education that joins the forces of biologists, geneticists, engineers and mathe…

Read more

Belgian scientists in Nature with cancer breakthrough

Scientists Peter Carmeliet and Sarah-Maria Fendt (KU Leuven/VIB) published in the prestigious Nature journal on their fundamental breakthrough in cancer research. They found a new way to prevent b…

Read more

Mmmm…… delicious, cultured meat

In 2013 the first cultured meat burger was a success. You take some tissue from livestock, purify the cells, give them broth to grow on in the lab, and you get a burger. Right now this process has…

Read more

Insights

Are the days of journal paywalls finally numbered?

Are the days of journal paywalls finally numbered?

Europe has taken an ambitious step forwards in the fight for open access to academic papers. On September 4th, Science Europe announced the launch of cOAlition S: an initiative to enforce open acc…

Read more

Cycling for Science

Cycling for Science

Researchers from Ghent University have been able to map the effects of climate change thanks to images of the Tour of Flanders. By studying 36 years of footage of the popular cycling race, the res…

Read more

Damya Laoui at the forefront of cancer immunotherapy

Damya Laoui at the forefront of cancer immunotherapy

Photo copyright: VUB / Thierry Geenen Last year, Damya Laoui received the prestigious American MIT-prize for young innovators under 35 for her research on cancer immunotherapy.  She is current…

Read more

CD3 as co-creator of drugs with academia and pharma

CD3 as co-creator of drugs with academia and pharma

The Center for Drug Design and Discovery (CD3), based in Leuven, bridges the gap between innovative biomedical research emerging from academic institutions or SMEs and pharmaceutical companies. Th…

Read more

Visualizing the deep with a drivable endoscope that crawls into the sinus anatomy!

Visualizing the deep with a drivable endoscope that crawls into the sinus anatomy!

Do you suffer from chronic sinusitis? 3NT Medical have developed a highly advanced endoscope that allows access, visualization and treatment of the remote sinuses, in a minimally invasive manner. …

Read more

From Academia to Industry: growing in new directions

From Academia to Industry: growing in new directions

What does it mean to “be a scientist”? People generally have a very academia-centric view: scientists do research, write grants and churn out papers. Yet there are many ways to work in a scientifi…

Read more

The biggest killer after malaria - How to tackle RSV?

The biggest killer after malaria - How to tackle RSV?

Respiratory syncytial virus (RSV) annually threatens many babies and there is currently no drug or vaccine to combat the disease. A lot of research and several clinical trials are ongoing. We spok…

Read more

Sylvie Janssens in Manhattan - Belgian scientist living abroad

Sylvie Janssens in Manhattan - Belgian scientist living abroad

Sylvie Janssens lives in Manhattan, New York, where she relocated after earning her PhD in biotechnology at Ghent University. She studied biomedical sciences at Ghent University, and prior to that…

Read more

Macrophages to protect you from asthma

Macrophages to protect you from asthma

It has long been known that exposure to microbes can play a protective role against the subsequent development of asthma. Researchers from GIGA of the University of Liège provide an explanation an…

Read more

Reversed Brexit: £250 million for Bart De Strooper's dementia research

Reversed Brexit: £250 million for Bart De Strooper's dementia research

The UK has pledged a budget of £250 million to the creation of the UK Dementia Research Institute (DRI). The institute hopes to assemble top-notch neurodegenerative research from around the countr…

Read more

Interspecies chimeras: One embryo, two species

Interspecies chimeras: One embryo, two species

The creation of an interspecies embryo in the lab sends tremors through the scientific world and beyond. This pig embryo containing human cells presents many exciting possibilities, such as creati…

Read more

ADHD, a disorder cured by play

ADHD, a disorder cured by play

In 2013, a new BioWin project, NeuroAtt, was launched to arrive at a reliable diagnosis for ADHD (Attention Deficit Hyperactivity Disorder) and to find the least invasive treatment for children. A…

Read more

Making water out of air

Making water out of air

A group of students from Ghent University is currently working on an innovative project that tackles the problem of drinking water scarcity. This project, called "Dewpal," will be their entry in T…

Read more

The PhD of Sue Ellen : Start small to dream big

The PhD of Sue Ellen : Start small to dream big

Sue Ellen Taelman studied bioscience engineering (with an emphasis on environmental technology) at Ghent University from 2007 until 2012. She wrote her master’s thesis on the sustainability of alg…

Read more

Huge steps forward in VIB skin cancer research

Huge steps forward in VIB skin cancer research

When it comes to finding a cure for melanoma skin cancer, major strides are being taken as we speak. One of the driving forces behind this great work is Chris Marine (VIB/KU Leuven). His team has …

Read more

Watch Liège becoming a major healthcare hub

Watch Liège becoming a major healthcare hub

Bridge 2 Health (B2H), previously known as sCINNAMIC, is a company whose mission  is to valorize biomedical research from the University of Liège (ULg) and the Liège University Hospital (CHU de Li…

Read more

I was published in science - A cocktail of bugs

I was published in science - A cocktail of bugs

Each one of us carries trillions and trillions of 'bugs', as Jeroen Raes (Group Leader at Bioinformatics and (eco-)systems biology lab, VIB/VUB/KU Leuven) likes to call them —micro-organisms that …

Read more

GlycoDelete: the road to plant-grown medicines

GlycoDelete: the road to plant-grown medicines

What if our pharmaceuticals could be grown in plants? It might sound like science fiction, but two VIB/UGent research groups are working hard to scrap the “fiction” part. In a recent paper publish…

Read more

ALS: A fierce diagnosis

ALS: A fierce diagnosis

Do you remember the Ice Bucket Challenge? Back in 2014, it was used to create awareness and collect donations for research to combat ALS (Amyotrophic Lateral Sclerosis), a severe neurodegenerative…

Read more

Zostera Marina’s dive into the blue - Published in Nature

Zostera Marina’s dive into the blue - Published in Nature

Seagrass genome provides insights into the way marine ecosystems might adapt to climate change Coastal ecosystems are highly productive and diverse, and seagrasses form the bedrock of these ha…

Read more

Sammson gene causes melanoma

Sammson gene causes melanoma

In collaboration with big N2N researchers from UGent, VIB scientists from KU Leuven have revealed a remarkable link between malignant melanoma and a non-coding RNA gene called SAMMSON. The SAMMSON…

Read more

Zebrafish reveal the secret origins of β-cells

Zebrafish reveal the secret origins of β-cells

How can we improve the treatment and quality of life of diabetic patients? One possible approach involves the renewal of pancreatic β-cells, which are responsible for the production of insulin. A …

Read more

Successful valorization of innovation: Paul Van Dun and Leuven R&D

Successful valorization of innovation: Paul Van Dun and Leuven R&D

Universities are a rich source of innovative ideas and discoveries, but the process of bringing them into the commercial realm is far from self-evident. When scientist-entrepreneurs need help sett…

Read more

Peter Verwilst in Seoul – Belgian scientist living abroad

Peter Verwilst in Seoul – Belgian scientist living abroad

For two and a half years now, Peter Verwilst has been working and living in one of the largest, most vibrant cities in the world, the South Korean capital Seoul. The working pressure is huge in th…

Read more

Skin on skin: Melanoma research at VIB

Skin on skin: Melanoma research at VIB

Melanoma is a particularly nasty type of skin cancer. It progresses and spreads very quickly, and in many cases it is resistant to chemotherapy. Currently, two VIB research groups are investigatin…

Read more

I was published in science! - Expanding the RNA alphabet

I was published in science! - Expanding the RNA alphabet

A completely new area of genetic research is on the rise. In the past two years, RNA epigenetics has increasingly intrigued researchers with the enormous amount of new information it potentially c…

Read more

The life of Paola: Always on the move

The life of Paola: Always on the move

Paola Masuzzo left Sicily to combine her love for mathematics with her passion for biology-driven questions. After Rome and Utah (US) she moved to Ghent, and is now focusing on cell migration, for…

Read more

Faeces transplant as treatment for Crohn's disease

Faeces transplant as treatment for Crohn's disease

Crohn’s disease is a complicated chronic disorder, the complexity of which has only become clear during the last decade. It has become increasingly evident that your food pattern and gut microbiot…

Read more

Ending Alzheimer's before it starts

Ending Alzheimer's before it starts

Sebastiaan Engelborghs is a neurologist specialized in neurodegenerative brain diseases and believes in the potential of early diagnosis for Alzheimer's disease. Engelborghs teaches neuroscienc…

Read more

Preventing cervical cancer: vaccinating or freezing?

Preventing cervical cancer: vaccinating or freezing?

The group of human papillomaviruses has over 100 types, of which at least thirteen can cause cancer. The virus is present in people all over the world and is mainly spread through sexual contact. …

Read more

UCL and de Duve institute publish the structure of a transmembrane reductase in Nature

UCL and de Duve institute publish the structure of a transmembrane reductase in Nature

Transmembrane reductases form an important group of enzymes in the thiol-redox chain, the mechanism by which bacteria cope with oxidative stress. Despite the significance of these electron carrier…

Read more

Birger Dieriks in Auckland - Belgian scientist living abroad

Birger Dieriks in Auckland - Belgian scientist living abroad

Birger Dieriks lives in Auckland, New Zealand. He studied Bioengineering at Ghent University. After finishing his studies he started a PhD at the Department Molecular Biotechnology with Prof Van O…

Read more

Novosides hits the sweet spot of glycoside synthesis

Novosides hits the sweet spot of glycoside synthesis

Linking a sugar moiety to small molecules alters their physicochemical properties, which can lead to a myriad of interesting applications. However, glycoside synthesis is no child’s play and was d…

Read more

Targeting the shape of protein aggregates to treat Parkinson’s

Targeting the shape of protein aggregates to treat Parkinson’s

Parkinson's disease (PD) is the second most common neurodegenerative disorder in the world. Similar to Multiple System Atrophy (MSA) and dementia with Lewy bodies (DLB), it is linked to the aggreg…

Read more

Sugar may not be the only culprit causing diabetes and obesity

Sugar may not be the only culprit causing diabetes and obesity

It may no longer be sufficient to limit your intake of sugary snacks or to spend hours in the gym to avoid diabetes and obesity, as the presence of food contaminants known as persistent organic po…

Read more

Arnout Voet in Tokyo - Belgian scientist living abroad

Arnout Voet in Tokyo - Belgian scientist living abroad

Working in a stimulating, constantly changing environment is essential for scientific research. This can only be achieved by challenging yourself to leave your comfort zone and gain international …

Read more

Key role for polyglutamine repeats in cell function

Key role for polyglutamine repeats in cell function

Scientists at VIB and KU Leuven have revealed that variable polyglutamine repeats in the DNA tune the function of the protein in which they reside. To date, these repeats were known only to cause …

Read more

Regenerative cells for treatment of Duchenne muscular dystrophy

Regenerative cells for treatment of Duchenne muscular dystrophy

Recent research conducted by Marinee Chuah and Thierry VandenDriessche (Gene Therapy and Regenerative Medicine) is being featured on the cover of the latest issue of Nature Protocols. They provide…

Read more

Leave your comfort zone if you aim for success

Leave your comfort zone if you aim for success

Peter Carmeliet is the director of the VIB’s Vesalius Research Center (VRC) and a leading Belgian scientist who pushes the boundaries in interdisciplinary research and aims to translate new insigh…

Read more

Pattern-creating bacteria designed by KULeuven students

Pattern-creating bacteria designed by KULeuven students

After successfully competing in four previous editions,  KU Leuven once again joins the iGEM (international Genetically Engineered Machine) – the most prestigious international students’ synthetic…

Read more

MS slowly but surely unravels its secrets

MS slowly but surely unravels its secrets

Piet Stinissen is Professor and Dean at the Faculty of Medicine and Life Sciences at the University of Hasselt, where he is head of the Immunology and Biochemistry laboratory. He is a biochemist a…

Read more

Starving cancer with a fat free diet

Starving cancer with a fat free diet

During the development of cancer, our metabolism is hijacked, and new blood vessels are formed to provide nutrients to the growing tumor. Scientists from VIB and KU Leuven are working on how to st…

Read more

I was published in Nature!

I was published in Nature!

Peter Vandenabeele is senior full professor at the Inflammation Research Center (IRC), a VIB department at the Ghent University. He recently published in Nature an original research paper on the r…

Read more

Dr Armpit to the rescue!

Dr Armpit to the rescue!

Chris Callewaert received a Master’s degree in Bioengineering at Ghent University in 2010. In February this year he successfully finished his PhD about body odor, and more specifically, that of sm…

Read more

Bio-batteries coming soon

Bio-batteries coming soon

Recently, scientists discovered an entirely new microbe that is capable of transferring electrical current. This electrified family member of the Desulfobaceae, while waiting for its scientific na…

Read more

VC Views

The leap from academia to industry

The leap from academia to industry

The earlier in development, the greater the risk. It’s an unspoken law in biotech that makes valorizing promising academic projects difficult to fund. Venture Capitalists (VCs) specialized in earl…

Read more

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Turnstone XpandInnovation V-Bio Ventures Biowin GSK Janssen UGent KU Leuven Flanders.bio Itera Life Science

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.